Cara Cassino
No más puestos en curso
Fortuna: - $ al 30/04/2024
Historial de carrera de Cara Cassino
Antiguos cargos conocidos de Cara Cassino.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CONTRAFECT CORPORATION | Director Técnico/Científico/I+D | 25/09/2015 | 14/08/2022 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/12/2014 | 01/09/2015 |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2008 | 01/01/2013 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Director Técnico/Científico/I+D | 01/01/2001 | 01/01/2007 |
| New York University School of Medicine | Corporate Officer/Principal | - | - |
Formación de Cara Cassino.
| NYU College of Dentistry | Undergraduate Degree |
| New York University School of Medicine | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CONTRAFECT CORPORATION | Health Technology |
| PFIZER, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT. | Health Technology |
- Bolsa de valores
- Insiders
- Cara Cassino
- Experiencia